C2 and bacterial infectious disease: However, S. aureus do possess terminal complement inhibitors such as SSL739,40 indicating a role for blocking MAC activity, and humans with deficiencies in early complement components (e.g., C1q, C2, C3, C4) are susceptible to multiple bacterial infections including S. aureus41.